Archive for the 'Cholesterol' Category
Explaining An Important Genetic Cardiovascular Risk Factor
New findings reported in the September issue of Cell Metabolism, a Cell Press publication, appear to explain why people who carry specific and common versions of a single gene are more likely to have high cholesterol and to suffer a heart attack. Studies in mice show that the gene, known as sortilin (SORT1), controls the release of LDL (a.k.a…
AHRQ Releases New Spanish Language Guides For Patients
HHS’ Agency for Healthcare Research and Quality today released a series of free evidence-based guides designed to help Spanish speakers understand and compare the risks, benefits and side effects of treatments for eight health conditions. The guides provide valuable information that patients can use in talking with their clinicians…
Non-stick Cookware And Waterproof Fabrics Linked To Higher Cholesterol Levels In Kids
Chemicals used in the production of non-stick cookware and waterproof fabrics, known as perfluoroalkyl acids, can get into children’s blood and raise their LDL cholesterol levels (”bad cholesterol” levels), says an article published in Archives of Pediatrics & Adolescent Medicine. Examples of perfluoroalkyl acids include PFOA (perfluorooctanoic acid) and PFOS (perfluorooctanesulfonate)…
Data From Mipomersen Phase 3 Trial In heFH Patients Presented At ESC
Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented at the European Society of Cardiology’s Congress 2010 in Stockholm, Sweden…
Netherlands Study Shows Need For Dose Management Care When Switching To Generic Statins
Research conducted in the Netherlands has highlighted the need for care when switching patients under treatment for high cholesterol from branded to generic drug families. The study shows that much of the switching can result in patients inadvertently receiving non-equivalent doses, potentially leading to an increased risk of downstream heart disease and stroke…
Grapefruit’s Bitter Taste Holds A Sweet Promise For Diabetes Therapy
Naringenin, an antioxidant derived from the bitter flavor of grapefruits and other citrus fruits, may cause the liver to break down fat while increasing insulin sensitivity, a process that naturally occurs during long periods of fasting…
Expanded Lipoprotein Testing, VAP® Cholesterol Test Discussed At National Lipid Association Summer Clinical Lipid Update
Atherotech Diagnostics Lab will exhibit its VAP® Cholesterol Test in booth 105 at the National Lipid Association (NLA) Summer 2010 Clinical Lipid Update. The meeting takes place August 27-29 at the Mayflower Hotel in Washington, D.C…
Impax Laboratories Confirms Patent Challenge Relating To VYTORIN(R), 10 Mg/80 Mg
Impax Laboratories, Inc. (NASDAQ: IPXL) today confirms that it has initiated a challenge of patents listed by MSP Singapore Co. LLC in connection with VYTORIN® (ezetimibe/simvastatin), 10 mg/80 mg. Impax filed its Abbreviated New Drug Application (”ANDA”) containing a paragraph IV certification for a generic version of VYTORIN® with the U.S. Food & Drug Administration (”FDA”)…
Outlets Should Offer Free Statins With Junk Food Say UK Researchers
Imagine this: order a cheeseburger and fries, and pick up a free cholesterol-busting statin tablet along with the other free condiments, that’s what a group of UK researchers suggests you should be able to do at fast food outlets as a way to offset the increase in heart attack risk from eating junk food…
Amarin’s AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment And Randomization
Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial…
